Podcasts about psychedelic drugs

Contributor: Jorge Chalit-Hernandez, OMS3 Educational Pearls: Psychedelics are being studied for their therapeutic effects in mental illnesses, including major depressive disorder, post-traumatic stress disorder, anxiety, and many others Classic psychedelics include compounds like psilocybin, LSD, and ayahuasca MDMA and ketamine are often included in psychedelic research, but have a different mechanism of action than the others Their mechanism of action involves agonism of the 5HT2A receptor, among others Given their resurgence, there is an increase in recreational use of these substances A recent study assessed the risks of recreational users developing subsequent psychotic disorders Individuals who visited the ED for hallucinogen use had a greater risk of being diagnosed with a schizophrenia spectrum disorder in the following 3 years Hazard ratio (HR) of 21.32 After adjustment for comorbid substance use and other mental illness, the hazard ratio was 3.53 - still a significant increase compared with the general population They also found an elevated risk for psychedelics when compared to alcohol (HR 4.66) and cannabis (HR 1.47) The study did not assess whether patients received antipsychotics or other treatments in the ED References Lieberman JA. Back to the Future - The Therapeutic Potential of Psychedelic Drugs. N Engl J Med. 2021;384(15):1460-1461. doi:10.1056/NEJMe2102835 Livne O, Shmulewitz D, Walsh C, Hasin DS. Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP. Addiction. 2022;117(12):3099-3109. doi:10.1111/add.15987 Myran DT, Pugliese M, Xiao J, et al. Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. JAMA Psychiatry. 2025;82(2):142-150. doi:10.1001/jamapsychiatry.2024.3532 Summarized & Edited by Jorge Chalit, OMS3 Donate: https://emergencymedicalminute.org/donate/  

Send us a textNew forms of life that were never meant to be. Drugs that open doorways to the other side. And a Juggalo who winds up at the mercy of a cult. This just scratches the surface of the darkness this story has to offer, Join us, and come down below...Annotations provided by Official Show Archivist Mary Anne Simpson.After this, I encourage you to listen toThicker Than Water, a new audio novel by yours truly. 11 hours of crime noir goodness, a savage tale of revenge, and family. I will be releasing the first couple of chapters right here, very soon. Its available for free on the patreon, but its also for sale! 10 bucks, no membership required. Music by:Serge Quadrado - documentary dark dunJIN – a blood red thing that writhesRoom of Wires – asylum sneakerFilmy Ghost – my mask is broken Please subscribe through Buzzsprout, Stitcher, Spotify, Podchaser, or iTunesFind me on social media on Instagram Facebook and Twitter, or email me direct at AScaryHomeCompanion@gmail.comSupport our PATREON page! And check out the Redbubble merch shop. Support the show

Mushrooms, Molly, Ecstasy, MDMA. Tune in tonight to hear just how experts believe these drugs might hold the key to not just battling but CURING PTSD, depression, and other mental health issues in veterans and active-duty service members. We're discussing Psychedelic drugs to treat veterans and active duty members suffering from PTSD and other mental health issues. 67% of veterans who participated in a new trial treated with MDMA say it cured or lessened their PTSD. They say it's time to drop the stigma and accept the fact that psychedelic drugs DO have healing powers that some even call – a miracle. We'll meet one of these veterans who says the therapy literally saved his life. Thank you to our sponsor: Beam: Visit https://ShopBeam.com/DrPhil and use code DRPHIL for up to 40% off.

A report gives an insight into how we're using pharmaceutical and psychedelic drugs. The 2024 New Zealand Drugs Trends Survey of more than 10,000 people shows a quarter of recent psychedelics users took the drugs for their mental health and wellbeing. Author Dr Robin van der Sanden says there's growing awareness among the general public about their potential benefits. She says it's a global trend, fuelled by things like recent clinical trials of LSD for terminal cancer patients. van der Sanden told Andrew Dickens that there is a concern about health and safety, namely mixing the substances with alcohol, or the risk of counterfeit pharmaceuticals. LISTEN ABOVE See omnystudio.com/listener for privacy information.

First up this week, Breakthroughs Editor Greg Miller joins producer Meagan Cantwell to discuss Science's 2024 Breakthrough of the Year. They also discuss some of the other scientific achievements that turned heads this year, from ancient DNA and autoimmune therapy, to precision pesticides, and the discovery of a new organelle.   Next, host Sarah Crespi is joined by news staffers to catch up on threads they've been following all year. First a bumpy road for certain medicines. Editor Kelly Servick discusses the regulatory hurdles for psychedelic drugs and immunotherapy treatments for Alzheimer's disease. Then we hear from Staff Writer Paul Voosen about why scientists think this will be the hottest year on record. Finally, what happened with fusion power this year? Staff Writer Daniel Clery brings updates.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Greg Miller; Meagan Cantwell; Kelly Servick; Daniel Clery; Paul Voosen

First up this week, Breakthroughs Editor Greg Miller joins producer Meagan Cantwell to discuss Science's 2024 Breakthrough of the Year. They also discuss some of the other scientific achievements that turned heads this year, from ancient DNA and autoimmune therapy, to precision pesticides, and the discovery of a new organelle.   Next, host Sarah Crespi is joined by news staffers to catch up on threads they've been following all year. First a bumpy road for certain medicines. Editor Kelly Servick discusses the regulatory hurdles for psychedelic drugs and immunotherapy treatments for Alzheimer's disease. Then we hear from Staff Writer Paul Voosen about why scientists think this will be the hottest year on record. Finally, what happened with fusion power this year? Staff Writer Daniel Clery brings updates.   This week's episode was produced with help from Podigy.   About the Science Podcast   Authors: Sarah Crespi; Greg Miller; Meagan Cantwell; Kelly Servick; Daniel Clery; Paul Voosen

Today's guest has an incredible story of transformation and healing. Once trapped in the cycle of emotional eating and a lifelong struggle with food, she faced deep trauma, disconnection, and a full-blown eating disorder. Through her journey, she discovered that true healing goes far beyond diet and nutrition. With advanced training in dietetics, functional medicine, and trauma-informed care, she now helps others uncover the root causes of their struggles, blending cutting-edge science with the power of emotional healing and even therapeutic psychedelics. As the founder of The Root Cause Method, she's helping people experience profound freedom—body, mind, and spirit. Please welcome Jillian Acosta.   Sign Up To Work With Melissa   Sign Up To Be A Guest On The Podcast!  Melissa's Recommendations & Affiliations  Get Melissa's Recommended Oura Ring  Follow Melissa on Instagram  Follow Melissa on Youtube  Find out more about Melissa  Get Access to the MADE Diet Course Get The MADE Diet Ebook  Learn More About Larimar Med's Services Follow Dr. Fitz on Instagram  Follow Dr. Fitz on Youtube Thank you so much for listening to this episode! We are honored and excited to be on this journey toward personal growth, a healthy lifestyle, and a greater more confident you. We'd love to hear from you. So, please share this episode with anyone you think needs to hear this message and remember to rate, review and subscribe wherever you listen to podcasts. We are Melissa McAllister & Dr. Lauren Fitzgerald. And until next time, thank you for being your own health advocate.  xo, Melissa & Dr. Fitz

In this episode, Souhad and Samia talk about psychedellic drugs and microdosing, relaying information from the media and a Webinar held by Dr Fademan from the USA.

CW: Please note, this episode is for informational and entertainment purposes only and does not constitute medical advice. While ongoing research explores the potential therapeutic benefits of psychedelics and cannabis, these substances remain illegal in the UK, and psychedelics are not yet approved treatments for mental health or neurological conditions.Dr. Rayyan Zafar is a leading neuropsychopharmacologist and a postdoctoral researcher at Imperial College London. In this chat with Ben, Dr. Zafar discusses how different substances, from Adderall to psychedelics, impact the neurodivergent brain, offering insights into the complex relationship between drugs and ADHD. Hosted on Acast. See acast.com/privacy for more information.

Dr. Daniel Stickler, a pioneer in systems-based precision performance medicine, introduces a new paradigm that shifts medicine from a symptom-based disease model to one focused on achieving peak performance in all aspects of life. You can listen to his full-length episode HERE on Spotify and HERE on Apple Podcasts.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Richard Miller is my special guest tonight to discuss how top researchers were carrying out experiments with psychedelic drugs under the direction of the government.  Embracing the revival of psychedelic research and the discovery of new therapeutic uses, clinical psychologist Dr. Richard Louis Miller discusses what is happening today in psychedelic medicine--and what will happen in the future--with top researchers and thinkers in this field, including Rick Doblin, Stanislav Grof, James Fadiman, Julie Holland, Dennis McKenna, David Nichols, Charles Grob, Phil Wolfson, Michael and Annie Mithoefer, Roland Griffiths, Katherine MacLean, and Robert Whitaker.  Dr. Miller and his contributors cover the tumultuous history of early psychedelic research brought to a halt 50 years ago by the U.S. government as well as offering non-technical summaries of the most recent studies with MDMA, psilocybin, LSD, and ayahuasca. They explore the biochemistry of consciousness and the use of psychedelics for self-discovery and healing. They discuss the use of psilocybin for releasing fear in the terminally ill and the potential for MDMA-assisted psychotherapy in the treatment of PTSD. They examine Dr. Charles Grob's research on the indigenous use and therapeutic properties of ayahuasca and Dr. Gabor Mate's attempt to transport this plant medicine to a clinical setting with the help of Canada's Department of National Health.  Dr. Miller and his contributors explore the ongoing efforts to restore psychedelic therapies to the health field, the growing threat of overmedication by the pharmaceutical industry, and the links between psychiatric drugs and mental illness. They also discuss the newly shifting political climate and the push for new research, offering hope for an end to the War on Drugs and a potential renaissance of research into psychedelic medicines around the world.Follow Our Other ShowsFollow UFO WitnessesFollow Crime Watch WeeklyFollow Paranormal FearsFollow Seven: Disturbing Chronicle StoriesJoin our Patreon for ad-free listening and more bonus content.Follow us on Instagram @mysteriousradioFollow us on TikTok mysteriousradioTikTok Follow us on Twitter @mysteriousradio Follow us on Pinterest pinterest.com/mysteriousradio Like us on Facebook Facebook.com/mysteriousradio

How psilocybin works on serotonin, the ‘feel good' hormone. Why people are using it for alcoholism, depression, PTSD, and anorexia. Ideas, anecdotes, data, studies - and the story of one woman on a mission to get us all re-thinking psychedelics from mushrooms to LSD.

LA-based Lipgloss drops in on the Moondog to share exclusive tracks. His debut album, Lick Our Lips, is out now! Tracklist "Elkka - D Flaw Aqua - Lollipop (ID Remix) T.J.Davis - Can You Feel the Sunshine? Alex Wilcox - Always Ginger Root - Linus N' Lucy Lipgloss Guest Mix: Lipgloss - ID Lipgloss - ID Lipgloss - This Energy Lipgloss - ID Lipgloss - ID Lipgloss - ID Lipgloss - ID Lipgloss - ID Lipgloss - ID Lipgloss - ID x (Dr. Frederick Barrett - The Neuroscience of Psychedelic Drugs, Music, and Nostalgia [TedTalk]) Justin Jay - Where is the PLUR? (Lipgloss FLIP) Lipgloss, Seanathan - Submissive & Breedable "

Text Me ImmediatelyOn this one I return from the long vacation I took to some tropical island.  As I write this, I realize that is exactly what I should have done.  It's been almost two weeks since the last episode, I couldn't get a guest, but had I made this a whole "I'm in the Bahamas podcasting live" thing, it would've given me volumes of material.  I could have talked about the present day political climate in the region today, maybe even talk about the current prime minister.  I don't even know if they have a prime minister.  Are they a country?  A territory?  Find out now in this episode!!!  Support the Show.Go to hunchbunny.com to see all the hidden secrets!!!

In this episode we have two interesting news stories from the unrelated worlds of infectious disease and psychedelic research. What's all the fuss with H5N1 moving into cows and is my milk safe? Plus a breakdown of a fascinating set of experiments aimed at answering whether MDMA increases empathy and why this could influence how doctors prescribe the drug in the future.This is the only link you need to subscirbe and never miss an episode of Two Brad For You. Please do rate and review it really helps us out.If you'd like to support the show with currency click here. We are grateful for that too. Finally, you can check out the website here.Many thanks to Freak Motif for the music and Sebastian Abboud for the logo. Listen to Two Brad For You Podcast: 'Mainstreaming' Psychedelic Drugs to Treat Mental Health - Brad van Paridon for Undark MagazineMDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbensThe H5N1 Outbreak Is Not a Test Run, It's a Warning ShotUS to test ground beef in states with bird-flu outbreaks in dairy cowsU.S. dairy farm worker infected as bird flu spreads to cows in five statesScientists call new measures to control bird flu in cows ‘a drop in the bucket'

Join Dr. Clancy and his guests, Dr. Flaum and Dr. Noupolos as they discuss the historical and current research on psilocybin and its potential use in the treatment of substance use disorders and major mental illnesses.  CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=66338  References/Resources:  Iowa Doctors Investigate the Healing Potential of Psychedelic Drugs. Iowa Magazine. https://magazine.foriowa.org/story.php?ed=true&storyid=2302 National Library of Medicine, ClinicalTrials.gov https://clinicaltrials.gov/  Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guests: Michael Flaum, MD Professor Emeritus in Psychiatry University of Iowa Carver College of Medicine Peggy Nopoulos, MD Chair and Department Executive Officer for the University of Iowa Department of Psychiatry Professor of Neurology, Pediatrics, and Psychiatry University of Iowa Carver College of Medicine   Financial Disclosures:  Dr. Gerard Clancy, his guests and the members of the planning committee for Rounding@IOWA have no relevant financial relationships to disclose. CME Credit Designation: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)  

In the last few years, there has been an increase in research around using psychedelic drugs, like LSD and magic mushrooms, as treatments for mental health conditions. And recently, two Canadian companies working in the sphere have gotten a special designation from a big U.S. regulator that could fast-track the development and review of their drugs.Sean Silcoff is a journalist with The Globe's Report on Business. He has been looking at recent developments in these companies and how that fits into the bigger picture of investor excitement around these drugs.Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com

Brad Young is At Your Service! In the second and final hour of tonight's show, Brad discusses the immigration issues at the border and the 5th U.S. Circuit Court of Appeals putting a Texas immigration law on hold. Also discussed on At Your Service: A Missouri bill may legalize psychedelic drugs for veterans and anyone 21 and older; and why it's wrong for the government to censor speech through private companies.

Australia is one of few countries in the world to allow psychedelic-assisted therapy to treat specific types of mental illness, under strict conditions. But use of the therapy, approved by the Therapeutic Goods Administration last year, has so far been very limited and more research is needed to understand the potential benefits and long-term effects. One study, by Monash University, is considering if psylocibin [[SY-luh-SY-bin]] - a compound found in magic mushrooms - can be effective in treating anxiety. - Австралия — одна из немногих стран в мире, где – при соблюдении строгих условий - разрешена терапия психоделиками для лечения определенных типов психических заболеваний.

In this new podcast episode, Isra Garcia presents 18 interviews focused on the field of psychedelics; those interviews feature 18 different profiles with stories, experiences, advice and recommendations from a myriad of experts, specialists, therapists, scientists, researchers, and curious enthusiasts from the industry. This conversation was kept during the Psychedelic Science 2023 conference in Denver (Colorado), where MAPS invited Isra to cover the event as a Spanish podcaster focused on psychedelics, human potential and peak performance. "Integration is on the backend of things but is also preparing the mind, soul and body... Develop your relationship and integration practice with the medicine" - Jeremy Colbert. The topics range from Psychedelics therapy, ketamin protocols and psychedelic peer support to integration coaching, and more. "In 1994, I announced to friends of mine, while I was in Grade School getting a master's Degree in Psychology, that I would devote myself to psychedelic psycho-assisted therapy when the time was right; I have been watching this, and I jumped as I soon as I could" - Sandra Newes "The most ancient technology we have is community healing" - Teresa Ting. Index of contents - and what you will learn in this episode: Introduction and context. Kira: volunteering with MAPS, diversity, education and the science behind it. Jeremy Colbert: integration coaching, a combination of psilocybin and ayahuasca, skills and tools for integration, where science meets spirituality. Teresa Yung: psychedelics and trauma working for the community space; how can we hold it, how can bring it, healing through peer support and the pinnacle of humankind. Sandra Newes: putting all your purpose on psychedelics, an online community for psychedelics providers for mental health, works better than anything else I've tried, bringing together the clinical, the physical, the medical, the spiritual and the shamanic. Gino Wilkins: questioning the status quo, reflective work, learning from the mistakes from the past, setting structures to build a more mindful psychedelic landscape. Nadia Van der Heyden: COO at Alvarius, researching with 5-Me0-DMT, its dicoveries and its potential benefits for treating addictions and other disorders, a full circle healing experience, big takeaways from taking psychedelics personally, and best advice. Mattha Louis Busby: journaling and wiriting for psychedelics, being in the present moment, releasing tension, investigative elements with the experiential, psychedelics in the UK, the proper integration ceases more psychedelic usage. Ron King: researching on psychedelic medicine, on the making of a psychedelic movie, the psychedelic work that is going on, a new beggining. Steven Turetsky: Irya Mosina: Julián Amaro: Kecho: Charlie: Natalie: Lauren M Hodge: Dylan Higginbotham: Kevin Cranford: working at MAPS, the largest psychedelic conference gathering, creating a bigger impact, his personal story. What's your psychedelic story? And ending. "When I was younger my dad had to go to prision for working with psychedelics and it was a very painful process for the family.. But now, 20-25 years later, become full circle where the same government that put him in prision is now giving him the license to produce and manufacture this drugs for research" - Nadia Van Der Heyden.  Podcast show notes and resources: MAPS. Rick Doblin Interview. Jeremy Colbert integration coach - Taragape  Instagram. Lorna Liana Spirit School. Being True to You Transformation Coaching and Training. The Trauma Project. Psychedelic Provider Network. Sandra Newes. The Living Medicine Institue. Gino Wilkins Linkedin. Nadia Van der Heyden LinkedIn. Alvarius. Peter Van Der Heyden. Mattha Link.tr. Uncharted Territory podcast. Viztor Movie. Psychedelic Science, Therapy, Experience: 18 Stories around psychedelics, human potential and, holistic healing and mental health - Disrupt Everything podcast by Isra Garcia #248

Australia is one of few countries in the the world to allow psychedelic-assisted therapy to treat specific types of mental illness, under strict conditions. But use of the therapy, approved by the Therapeutic Goods Administration last year, has so far been very limited and more research is needed to understand the potential benefits and long-term effects. One study, by Monash University, is considering if psylocibin [[SY-luh-SY-bin]] - a compound found in magic mushrooms - can be effective in treating anxiety.

Pink Sheet reporters and editors discuss the FDA's approach to psychedelic drugs (:25), whether postmarket clinical trial data from the Alzheimer's drug Aduhelm will be published (16:32), and the FDA offering more time to find candidates for its new Genetic Metabolic Diseases Advisory Committee (27:19). More On These Topics From The Pink Sheet Lykos' MDMA NDA Leads Upcoming Tests Of US FDA's Psychedelics Draft Guidance: https://pink.citeline.com/PS149813/Lykos-MDMA-NDA-Leads-Upcoming-Tests-Of-US-FDAs-Psychedelics-Draft-Guidance For Psychedelics, US FDA Is Open To Creative Thinking But Firm On Approval Standards: https://pink.citeline.com/PS149812/For-Psychedelics-US-FDA-Is-Open-To-Creative-Thinking-But-Firm-On-Approval-Standards A Visual Trip Through The Psychedelic Pipeline: https://pink.citeline.com/PS149831/A-Visual-Trip-Through-The-Psychedelic-Pipeline Aduhelm's Post-Marketing Studies: At Least One More Data Dump Likely Required By NIH: https://pink.citeline.com/PS149826/Aduhelms-Post-Marketing-Studies-At-Least-One-More-Data-Dump-Likely-Required-By-NIH New US FDA Genetic Metabolic Adcomm Needs More Candidates: https://pink.citeline.com/PS149819/New-US-FDA-Genetic-Metabolic-Adcomm-Needs-More-Candidates

Regularly referred to as "The most famous Nordic Artist since Edvard Munch," painter, sculptor, filmmaker and installation artist Bjarne Megaard joins the audiocast to dish on decades in the art world. Topics covered: Bjarne's new film Barney Does it All based on his time as a whore in Sydney, his interview with porno actress Rae Lil Black in the new issue of Richardson Mag, the perpetual antagonism between him at the art world and the cowardice of curators, his former financial backers who fucked him out of millions, drug addiction, ketamine therapy, fashion, anabolic steroids and being asked to be Mr. Miami, hanging out and working with the stars of Norwegian black metal, and much more... FULL EPISODE HERE Bjarne's new film and exhibition opens at Faurschou Gallery in NY on Feb 7 SOUNDTRACK: Darkthrone "In the Shadow of the Horns" Larm "Chemical Suicide" Thorns "Stellar Master Elite" Miss Kittin and the Hacker "Homme a La Mode" Pure "Nigredo" Eric's Trip "Follow"  LINKS: Bjarne at Instagram: @bjarnemelgaard Bjarne at Thaddeus Ropac Faurschou Gallery Richardson Magazine A11

⭐️ ELASTIC PERCEPTION LEARN TO ASTRAL PROJECT

The staff at Everyone Dies is taking a much-needed break this December, so we will be re-publishing some of our greatest hits with updated topical information as an introduction. This week we talk about the use of psychedelic drugs from the perspective of the scientist who legitimized the study of these drugs at Johns Hopkins University.In this Episode:00:00 – Dr. Roland Griffiths on his psychedelic inquiry with terminal cancer06:35 – Intro (Episode is a re-run from S3E28)10:38 – Five Little-Known Facts about Psychedelics17:18 – Entheogens and Psychedelics39:39 – Willie Nelson – "Dusty Bottles"42:54 – OutroFollow us on Facebook | Instagram | Email us at mail@every1dies.orgClick on this link to Rate and Review our podcast!

Some crazy industry news this week involving a jumpseating pilot, Joseph Emerson, that was charged with attempted murder after trying to shut down the engines of an airliner in flight. We also cover the story of an A321 that departed with cabin windows missing, and a Hawker 800 that collided with a Cessna Mustang at the Houston Hobby airport. Alaska Airlines pilot accused of trying to crash plane may have taken psychedelic mushrooms: https://youtu.be/wp6OiYd7-zw?si=76UXseQCmomjSHYG Titan Airways Airbus A321LR Took Off From London Stansted With Window Missing: https://youtu.be/PKBuEt1mSE8?si=dmaNwpVLvbEsmcTF Private Jets COLLIDE ON TAKEOFF & LANDING | Runway Incursion: https://youtu.be/ANJq5wBaXmE?si=SEO9Hi-4L-K4Kg-j NEW!!! DON'T MISS THIS! Go to https://www.propilotplaybook.com and enter your email to get access to our list of "The Top 10 Flight School Ripoffs" and access to free lesson from our course. If you have a question you'd like us to answer, you can email us at: podcast@propilotplaybook.com   Chapters: 00:00 Intro & Where have we been? 03:39 Shrooms, Missing windows, Mid-ground 04:48 Drugs in the jump seat 13:00 Opening a door in flight 14:35 Pilots with depression 21:33 Airbus airliner missing windows 25:52 Hawker hits a Cessna during takeoff at Houston Hobby 28:49 Comair crash at Lexington 35:07 Experience level of today's pilots 38:37 Taking action & Pro-Pilot Playbook Course

Unlock aspects of your personality that you never knew were possible with NR2B. In this episode, we uncover how we can increase metaplasticity in the brain, drugs that alter consciousness and much more.Where I Buy Most of These Dopamine Boosting Supplements: https://cosmicnootropic.com/?aff=181Get 10% off 9-MBC, Bromantane and SR9009 here: https://science.bio/steveglaveski10 (use code: steveglaveski10) Buy High-Quality TUDCA, BPC-157, and GI Repair supplements here (10% Discount Code: FUTURE): https://lvluphealth.com/STEVEGLAVESKIFree Cheatsheet: 5 Epic Supplement Stacks For Energy, Motivation And Focus: https://bit.ly/suppstackcheatsheet Want More Energy, Motivation & Focus? Apply For My Limitless Men's Energy Program Here: https://bit.ly/LimitlessProgram Hosted on Acast. See acast.com/privacy for more information.

Guest: Leonie Joubert is a South African science writer and author dedicated to various critical studies in the realm of public mental health and she joins Amy to discuss a controversial global movement to decriminalise the use of psychedelics to treat some mental health conditions.See omnystudio.com/listener for privacy information.

Now, it is another edition of the Midday Healthwatch with Dr. Leana Wen, one of the most respected public health experts in the country. She's a former health commissioner of Baltimore. She's a columnist on health matters for the Washington Post, a medical expert on CNN, and a scholar at George Washington University and the Brookings Institution.Email us at midday@wypr.org, tweet us: @MiddayWYPR, or call us at 410-662-8780.

Welcome to the second part of our groundbreaking two-part series on the Ramos Law Difference Makers Podcast, featuring Dr. Don Cooper, head of the Medical Sciences Division at Ramos Law. In this continuation of our exploration into the world of psilocybin, Dr. Cooper delves even deeper into this intriguing compound. Part 2 unravels the prevailing theories regarding the subjective effects of psilocybin, offering valuable insights into how individuals experience enhanced connectivity between brain regions not typically connected while on this substance. Dr. Cooper sheds light on its clinical therapeutic applications, highlighting the promising strides being made in using psilocybin as a tool for treatment of depression, anxiety, PTSD, and more. Furthermore, this episode also tackles essential safety concerns, including potential adverse effects like psychological disturbances and how the set and setting in which individuals take psilocybin is vitally important. Learn more about Dr. Cooper and Ramos Law's Medical Sciences Division ⬇️ https://www.ramoslaw.com/medical-sciences/

Hour 3 of The Drew Mariani Show on 9-7-23 Matthew Brueninger takes a look at the rise in psychedelic drug use, and therapies that have been developed around these drugs Monsignor Stephen Rosetti, as an exorcist, talks about how illicit drugs can open you up to the demonic

Birth control is more accessible than ever before. Then, psychedelic drugs may help brain development. And finally… new plastic could help recycling efforts. Learn More: https://radiohealthjournal.org/medical-notes-over-the-counter-contraception-biodegradable-plastic-and-how-psychedelic-drugs-help-brain-development Learn more about your ad choices. Visit podcastchoices.com/adchoices

TWiN explains how psychedelic drugs such as LSD, psilocybin, and MDMA, which are being explored for treating a wide range of neuropsychiatric diseases, reopen the social reward period for critical learning. Hosts: Vincent Racaniello, Jason Shepherd, and Timothy Cheung Click arrow to play Download TWiN 042 (34 MB .mp3, 57 min) Subscribe (free): Apple Podcasts, Google Podcasts, RSS Links for this episode MicrobeTV Discord Server Psychedelic drugs open critical period (Nature) Psychedelics reopen critical periods (News-Med) LSD microdosing doesn't work (U Chicago Med) Timestamps by Jolene. Thanks! Music is by Ronald Jenkees Send your neuroscience questions and comments to twin@microbe.tv

In this episode, we discuss new research into psychedelic drugs as potential therapies for psychiatric illness. Several studies have suggested that drugs, such as psilocybin, may be useful in treating problems such as post-traumatic stress disorder, addiction and depression. Psychiatry researchers at Washington University School of Medicine in St. Louis have been using a brain-imaging technique called precision functional mapping to learn how psilocybin affects certain networks in the brain. Principal investigator Ginger Nicol, MD, an associate professor of child psychiatry, says scientists have suspected since the 1950s that there may be benefits from some psychedelic drugs, but because the drugs were classified as schedule one substances, researchers weren't allowed to study them. Recently, that has changed and Nicol, with fellow psychiatry researcher Josh Siegel, MD, PhD, gave a lecture sponsored by Washington University's Taylor Family Institute for Innovative Psychiatric Research, outlining some potential benefits of psychedelics in addressing hard-to-treat psychiatric problems. Using high-tech brain scans, they have been able to see what happens in the brain when a person takes psychedelic drugs, and they've found that the drugs cause more rapid changes than other medications used in psychiatry. What they want to learn next is whether the responses they've observed in brain scans translate into similar responses in the clinic, which could lead to improved mental health. They are planning to participate in a phase 3 clinical trial using psilocybin to treat people with treatment-resistant depression. The podcast, “Show Me the Science,” is produced by WashU Medicine Marketing & Communications at Washington University School of Medicine in St. Louis.

Jaden Smith Claims His Mom Introduced The Family To Psychedelic Drugs! Learn more about your ad choices. Visit megaphone.fm/adchoices

This week on Jesuitical, Ashley and Zac chat with Bryan McCarthy, who teaches philosophy at the University of Pittsburgh, Greensburg, and is the author of a new paper, “Christianity and Psychedelic Medicine: A Pastoral Approach.” They discuss:  What the church teaches about drugs and intoxication How psychedelic drugs are being used in therapeutic settings, and how Christians should respond Bryan's own religious experiences while using psychedelic drugs  During Signs of the Times, Ashley and Zac give initial reactions to the new working document for the Synod on Synodality and discuss a curious story involving a fake priest and serious labor violations out of California.  Links from the show:  Bryan's paper Vatican releases Synod document calling for discussion of women, LGBT Catholics, church authority and more California restaurant had fake priest hear workers' confessions, Labor Department says Learn more about your ad choices. Visit megaphone.fm/adchoices

Aaron Rodgers wants legalized psychedelic drugs To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

A controversy erupted at a blue marlin fishing tournament after a 619-pound catch was disqualified. A submersible with five tourists to see the Titanic, has gone missing. The number of teens who make disparaging comments about themselves has doubled in the past decade. Castrated men are fighting on the front lines against the Russians. They are trying to pass a bill for psychedelic drugs to treat PTSD. A teacher resigned because a 12-year-old would make fun of them for being Jewish.

Psychedelic drugs have long been been used for their mind-altering effects. Now, they are making their way into western medicine as a treatment for mental health disorders. From July, psychiatrists in Australia will be able to prescribe MDMA for post-traumatic stress disorder, making it the first country in the world to recognise psychedelics as medicines. The US could soon follow, with plans for the US Food and Drug Administration to be asked for approval to treat PTSD with MDMA this year. Ian Sample speaks to correspondent Hannah Devlin about how the science behind psychedelic therapy has progressed, and hears from Prof Celia Morgan about what treatment is actually like, what we know about the risks and what's left to learn. Help support our independent journalism at theguardian.com/sciencepod

Guest host Richard Syrett and author Stephen Gray discuss his research into psychedelic drugs and spiritual enlightenment, how to use them safely under controlled circumstances, and how they rewire the brain to become aware of a new reality.See omnystudio.com/listener for privacy information.